Transcranial direct current stimulation over the right parietal cortex improves the depressive disorder: A preliminary study

Author:

Guo Xin123,Zhou Qilin45,Lu Yueying6,Xu Zhexue4,Wen Zhenye7,Gu Ping123,Tian Shujuan123ORCID,Wang Yuping23489ORCID

Affiliation:

1. Department of Neurology The First Hospital of Hebei Medical University Shijiazhuang Hebei China

2. Department of Neurology Hebei Hospital, Xuanwu Hospital, Capital Medical University Shijiazhuang China

3. Neuromedical Technology Innovation Center of Hebei Province Shijiazhuang China

4. Department of Neurology Xuanwu Hospital Capital Medical University Beijing China

5. Department of Neurology Fuwai Hospital, Chinese Academy of Medical Sciences Beijing China

6. Department of Clinical Psychology The First Hospital of Hebei Medical University Shijiazhuang Hebei China

7. Department of Rehabilitation The First Hospital of Hebei Medical University Shijiazhuang Hebei China

8. Beijing Key Laboratory of Neuromodulation Beijing China

9. Center for Sleep and Consciousness Disorders Beijing Institute for Brain Disorders Beijing China

Abstract

AbstractObjectiveThe right posterior parietal cortex is the core brain region of emotional processing and executive control network in the human brain, and the function of the right posterior parietal cortex is decreased in patients with major depressive disorder. This study aims to preliminarily investigate whether the excitation of the right posterior parietal cortex by transcranial direct current stimulation (tDCS) could improve their clinical symptoms.MethodsIn this study, 12 patients with major depressive disorder were given tDCS treatment at Xuanwu Hospital of Capital Medical University and the First Hospital of Hebei Medical University. The stimulating electrode (anode) was placed on the patients’ right parietal cortex, whereas the reference electrode (cathode) was placed on the patients’ left mastoid. The stimulation intensity was set as 2.0 mA. The patients with depressive disorder were treated for 20 min at a time twice a day for 14 consecutive days. The severity of the clinical symptoms was evaluated using the Hamilton Depression Rating Scale‐17 (HDRS‐17) and the Hamilton Anxiety Rating Scale (HARS) at before and right after treatment.ResultsThe HDRS‐17 scores of patients with depressive disorder decreased significantly following the tDCS treatment compared with those before treatment (< .001). Further analysis revealed that the patients’ anxiety/somatization, cognitive deficit, retardation, and sleep disorder scores all decreased significantly after the tDCS treatment (< .05), although there was no significant change in their weight. Moreover, the patients’ HARS scores decreased significantly after the tDCS treatment when compared with those before treatment (< .01).ConclusionThe right parietal cortex may be another key stimulation targets to improving the efficacy of tDCS treatment to the patients with major depressive disorder.

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3